[1] Gonzalez M, March AR.Tongue Cancer[M]. In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing, 2021.
[2] Faisal M, Dhanani R, Ullah S, et al.Prognostic outcomes of treatment naïve oral tongue squamous cell carcinoma (OTSCC): a comprehensive analysis of 14 years[J]. Eur Arch Otorhinolaryngol, 2020, 278(8): 3045-3053.
[3] 李金. 2005-2013年中国口腔癌及口咽癌发病率与死亡率趋势分析[A]. 2019第一届全国口腔颌面-头颈肿瘤学术大会—聚合引领、协同发展论文汇编[C]. 上海:2019第一届全国口腔颌面-头颈肿瘤学术大会,2019.
[4] Tang M, Dai W, Wu H, et al.Transcriptome analysis of tongue cancer based on highthroughput sequencing[J]. Oncol Rep, 2020, 43(6): 2004-2016.
[5] Oliveira LL, Bergmann A, Melo AC, et al.Prognostic factors associated with overall survival in patients with oral cavity squamous cell carcinoma[J]. Med Oral Patol Oral Cir Bucal, 2020 , 25(4): e523-e531.
[6] 魏泰,叶鹏,孙凤. CMTM7在舌鳞状细胞癌中的表达及对舌癌细胞增殖和迁移的影响[J]. 中国临床药理学杂志,2021,37(7):851-854.
[7] 郑欣雨,马晓娟,顾鹏,等. 运用超声检查对原发性舌癌诊断的应用价值[J]. 影像研究与医学应用,2020,4(9):1-2.
[8] Mascitti M, Zhurakivska K, Togni L, et al.Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma[J]. Histopathology, 2020, 77(5): 810-822.
[9] Ueshima K, Ogasawara S, Ikeda M, et al.Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma[J]. Liver Cancer, 2020, 9(5): 583-595.
[10] Ye M, Li X, Liu W, et al.Evaluating the efficacy and safety of continuous arterial infusion chemotherapy with cisplatin and 5-fluorouracil in treating oral cancer[J]. J Cancer Res Ther, 2016, 12(Supplement): 47-49.
[11] Nozato T, Koizumi T, Hayashi Y, et al.Thermochemoradiotherapy Using Superselective Intra-arterial Infusion for Patients With Oral Cancer With Cervical Lymph Node Metastases[J]. Anticancer Res, 2019, 39(3): 1365-1373.
[12] 宁尚波,杨东红,付爽. 选择性动脉灌注化疗在口腔癌治疗中的进展[J]. 医学信息,2018,31(3):28-30.
[13] Naruse T, Yanamoto S, Okuyama K, et al.Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence[J]. Pathol Oncol Res, 2020, 26(2): 735-742.
[14] Nasser H, St John MA.The promise of immunotherapy in the treatment of young adults with oral tongue cancer[J]. Laryngoscope Investig Otolaryngol, 2020, 5(2): 235-242.
[15] Faisal M, Dhanani R, Ullah S, et al.Correction to: Prognostic outcomes of treatment naïve oral tongue squamous cell carcinoma (OTSCC): a comprehensive analysis of 14 years[J]. Eur Arch Otorhinolaryngol, 2021, 278(8): 3055.
[16] Yang G, Li Z, Chen L.Limonin suppresses the progression of oral tongue squamous cell carcinoma via inhibiting YAP transcriptional regulatory activity[J]. Tissue Cell, 2020, 65: 101346. |
